The MaxDiscovery™ Ferritin ELISA Kit is an enzyme immunoassay that analyzes the quantity of human ferritin in cells, tissues or serum. Ferritin is a 450 kDa ubiquitous protein consisting of 24 subunits that stores iron and releases it in a controlled fashion. The protein acts as a buffer against iron deficiency and iron overload. One of the most prevalent disorders of man is the dietary deficiency of iron and the resulting anemia. Therefore, the assays of iron, total iron binding capacity and other assessments of iron compounds in the body are clinically significant. The presence of iron itself is a major trigger for the production of ferritin, with some exceptions. Free iron is toxic to cells and thus vertebrates use elaborate protective mechanisms. Under steady state conditions the serum ferritin level correlates with total body iron stores. Thus, serum ferritin is the most convenient laboratory test to estimate iron stores. Like most ELISA assays, the MaxDiscovery™ Ferritin ELISA Kit relies on Horseradish Peroxidase (HRP) and the (3,3´,5,5´-tetramethylbenzidine) TMB substrate. TMB is a chromogen that yields a blue color when oxidized with hydrogen peroxide (catalyzed by HRP) and has major absorbances at 370 nm and 652 nm. The color then changes to yellow with the addition of acid with maximum absorbance at 450 nm. The relative amount of ferritin protein in the cells will be directly proportional to the amount of signal that is obtained at 450 nm.
Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Enzyme Links Age-Related Inflammation, Cancer Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration. New Biomarker to Assess Stem Cells Developed A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.Therapy Halts Progression of Lou Gehrig’s Disease Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.Crouching Protein, Hidden Enzyme A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.HIV Protein Manipulates Hundreds of Human Genes Findings search for new or improved treatments for patients with AIDS.First 3-D Vision of Cancer Target This basic research set the grounds for structure-based drug design approaches that could be beneficial for cancer treatments' - Dr. Cyril Dominguez, University of Leicester.New Light Shed on Genetic Regulation A team of scientists has uncovered greater intricacy in protein signaling than was previously understood, shedding new light on the nature of genetic production.Hacking the Programs of Cancer Stem Cells All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.